Clinical trial

SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs

NCT04764214

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-01

PhasePHASE2

Study timeline

Study start (actual)2021-03-01Date precision: day

Registry last updated2024-08-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC Stage IVunresolved

EGFR Activating Mutationunresolved

Interventions

3rd generation EGFR-TKIDRUG

Consolidative SRTRADIATION

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04764214 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.